Tag Archives: fred

#436200 AI and the Future of Work: The Economic ...

Posted on November 22, 2019 by Android

This week at MIT, academics and industry officials compared notes, studies, and predictions about AI and the future of work. During the discussions, an insurance company executive shared details about one AI program that rolled out at his firm earlier this year. A chatbot the company introduced, the executive said, now handles 150,000 calls per month.

Later in the day, a panelist—David Fanning, founder of PBS’s Frontline—remarked that this statistic is emblematic of broader fears he saw when reporting a new Frontline documentary about AI. “People are scared,” Fanning said of the public’s AI anxiety.

Fanning was part of a daylong symposium about AI’s economic consequences—good, bad, and otherwise—convened by MIT’s Task Force on the Work of the Future.

“Dig into every industry, and you’ll find AI changing the nature of work,” said Daniela Rus, director of MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL). She cited recent McKinsey research that found 45 percent of the work people are paid to do today can be automated with currently available technologies. Those activities, McKinsey found, represent some US $2 trillion in wages.

However, the threat of automation—whether by AI or other technologies—isn’t as new as technologists on America’s coasts seem to believe, said panelist Fred Goff, CEO of Jobcase, Inc.

“If you live in Detroit or Toledo, where I come from, technology has been displacing jobs for the last half-century,” Goff said. “I don’t think that most people in this country have the increased anxiety that the coasts do, because they’ve been living this.”

Goff added that the challenge AI poses for the workforce is not, as he put it, “getting coal miners to code.” Rather, he said, as AI automates some jobs, it will also open opportunities for “reskilling” that may have nothing to do with AI or automation. He touted trade schools—teaching skills like welding, plumbing, and electrical work—and certification programs for sales industry software packages like Salesforce.

On the other hand, a documentarian who reported another recent program on AI—Krishna Andavolu, senior correspondent for Vice Media—said “reskilling” may not be an easy answer.

“People in rooms like this … don’t realize that a lot of people don’t want to work that much,” Andavolu said. “They’re not driven by passion for their career, they’re driven by passion for life. We’re telling a lot of these workers that they need to reskill. But to a lot of people that sounds like, ‘I’ve got to work twice as hard for what I have now.’ That sounds scary. We underestimate that at our peril.”

Part of the problem with “reskilling,” Andavolu said, is that some high-growth industries involve caregiving for seniors and in medical facilities—roles which are traditionally considered “feminized” careers. Destigmatizing these jobs, and increasing the pay to match the salaries of displaced jobs like long-haul truck drivers, is another challenge.

Daron Acemoglu, MIT Institute Professor of Economics, faulted the comparably slim funding of academic research into AI.

“There is nothing preordained about the progress of technology,” he said. Computers, the Internet, antibiotics, and sensors all grew out of government and academic research programs. What he called the “blue-sky thinking” of non-corporate AI research can also develop applications that are not purely focused on maximizing profits.

American companies, Acemoglu said, get tax breaks for capital R&D—but not for developing new technologies for their employees. “We turn around and [tell companies], ‘Use your technologies to empower workers,’” he said. “But why should they do that? Hiring workers is expensive in many ways. And we’re subsidizing capital.”

Said Sarita Gupta, director of the Ford Foundation’s Future of Work(ers) Program, “Low and middle income workers have for over 30 years been experiencing stagnant and declining pay, shrinking benefits, and less power on the job. Now technology is brilliant at enabling scale. But the question we sit with is—how do we make sure that we’re not scaling these longstanding problems?”

Andrew McAfee, co-director of MIT’s Initiative on the Digital Economy, said AI may not reduce the number of jobs available in the workplace today. But the quality of those jobs is another story. He cited the Dutch economist Jan Tinbergen who decades ago said that “Inequality is a race between technology and education.”

McAfee said, ultimately, the time to solve the economic problems AI poses for workers in the United States is when the U.S. economy is doing well—like right now.

“We do have the wind at our backs,” said Elisabeth Reynolds, executive director of MIT’s Task Force on the Work of the Future.

“We have some breathing room right now,” McAfee agreed. “Economic growth has been pretty good. Unemployment is pretty low. Interest rates are very, very low. We might not have that war chest in the future.” Continue reading →

Posted in Human Robots

#435626 Video Friday: Watch Robots Make a Crepe ...

Posted on September 13, 2019 by Android

Video Friday is your weekly selection of awesome robotics videos, collected by your Automaton bloggers. Every week, we also post a calendar of upcoming robotics events; here's what we have so far (send us your events!):

Robotronica – August 18, 2019 – Brisbane, Australia
CLAWAR 2019 – August 26-28, 2019 – Kuala Lumpur, Malaysia
IEEE Africon 2019 – September 25-27, 2019 – Accra, Ghana
ISRR 2019 – October 6-10, 2019 – Hanoi, Vietnam
Ro-Man 2019 – October 14-18, 2019 – New Delhi
Humanoids 2019 – October 15-17, 2019 – Toronto
ARSO 2019 – October 31-November 2, 2019 – Beijing
ROSCon 2019 – October 31-November 1, 2019 – Macau
IROS 2019 – November 4-8, 2019 – Macau
Let us know if you have suggestions for next week, and enjoy today's videos.

Team CoSTAR (JPL, MIT, Caltech, KAIST, LTU) has one of the more diverse teams of robots that we’ve seen:

[ Team CoSTAR ]

A team from Carnegie Mellon University and Oregon State University is sending ground and aerial autonomous robots into a Pittsburgh-area mine to prepare for this month’s DARPA Subterranean Challenge.

“Look at that fire extinguisher, what a beauty!” Expect to hear a lot more of that kind of weirdness during SubT.

[ CMU ]

Unitree Robotics is starting to batch-manufacture Laikago Pro quadrupeds, and if you buy four of them, they can carry you around in a chair!

I’m also really liking these videos from companies that are like, “We have a whole bunch of robot dogs now—what weird stuff can we do with them?”

[ Unitree Robotics ]

Why take a handful of pills every day for all the stuff that's wrong with you, when you could take one custom pill instead? Because custom pills are time-consuming to make, that’s why. But robots don’t care!

Multiply Labs’ factory is designed to operate in parallel. All the filling robots and all the quality-control robots are operating at the same time. The robotic arm, in the meanwhile, shuttles dozens of trays up and down the production floor, making sure that each capsule is filled with the right drugs. The manufacturing cell shown in this article can produce 10,000 personalized capsules in an 8-hour shift. A single cell occupies just 128 square feet (12 square meters) on the production floor. This means that a regular production facility (~10,000 square feet, or 929 m2 ) can house 78 cells, for an overall output of 780,000 capsules per shift. This exceeds the output of most traditional manufacturers—while producing unique personalized capsules!

[ Multiply Labs ]

Thanks Fred!

If you’re getting tired of all those annoying drones that sound like giant bees, just have a listen to this turbine-powered one:

[ Malloy Aeronautics ]

In retrospect, it’s kind of amazing that nobody has bothered to put a functional robotic dog head on a quadruped robot before this, right?

Equipped with sensors, high-tech radar imaging, cameras and a directional microphone, this 100-pound (45-kilogram) super-robot is still a “puppy-in-training.” Just like a regular dog, he responds to commands such as “sit,” “stand,” and “lie down.” Eventually, he will be able to understand and respond to hand signals, detect different colors, comprehend many languages, coordinate his efforts with drones, distinguish human faces, and even recognize other dogs.

As an information scout, Astro’s key missions will include detecting guns, explosives and gun residue to assist police, the military, and security personnel. This robodog’s talents won’t just end there, he also can be programmed to assist as a service dog for the visually impaired or to provide medical diagnostic monitoring. The MPCR team also is training Astro to serve as a first responder for search-and-rescue missions such as hurricane reconnaissance as well as military maneuvers.

[ FAU ]

And now this amazing video, “The Coke Thief,” from ICRA 2005 (!):

[ Paper ]

CYBATHLON Series put the focus on one or two of the six disciplines and are organized in cooperation with international universities and partners. The CYBATHLON Arm and Leg Prosthesis Series took place in Karlsruhe, Germany, from 16 to 18 May and was organized in cooperation with the Karlsruhe Institute of Technology (KIT) and the trade fair REHAB Karlsruhe.

The CYBATHLON Wheelchair Series took place in Kawasaki, Japan on 5 May 2019 and was organized in cooperation with the CYBATHLON Wheelchair Series Japan Organizing Committee and supported by the Swiss Embassy.

[ Cybathlon ]

Rainbow crepe robot!

There’s also this other robot, which I assume does something besides what's in the video, because otherwise it appears to be a massively overengineered way of shaping cooked rice into a chubby triangle.

[ PC Watch ]

The Weaponized Plastic Fighting League at Fetch Robotics has had another season of shardation, deintegration, explodification, and other -tions. Here are a couple fan favorite match videos:

[ Fetch Robotics ]

This video is in German, but it’s worth watching for the three seconds of extremely satisfying footage showing a robot twisting dough into pretzels.

[ Festo ]

Putting brains into farming equipment is a no-brainer, since it’s a semi-structured environment that's generally clear of wayward humans driving other vehicles.

[ Lovol ]

Thanks Fan!

Watch some robots assemble suspiciously Lego-like (but definitely not actually Lego) minifigs.

[ DevLinks ]

The Robotics Innovation Facility (RIFBristol) helps businesses, entrepreneurs, researchers and public sector bodies to embrace the concept of ‘Industry 4.0'. From training your staff in robotics, and demonstrating how automation can improve your manufacturing processes, to prototyping and validating your new innovations—we can provide the support you need.

[ RIF ]

Ryan Gariepy from Clearpath Robotics (and a bunch of other stuff) gave a talk at ICRA with the title of “Move Fast and (Don’t) Break Things: Commercializing Robotics at the Speed of Venture Capital,” which is more interesting when you know that this year’s theme was “Notable Failures.”

[ Clearpath Robotics ]

In this week’s episode of Robots in Depth, Per interviews Michael Nielsen, a computer vision researcher at the Danish Technological Institute.

Michael worked with a fusion of sensors like stereo vision, thermography, radar, lidar and high-frame-rate cameras, merging multiple images for high dynamic range. All this, to be able to navigate the tricky situation in a farm field where you need to navigate close to or even in what is grown. Multibaseline cameras were also used to provide range detection over a wide range of distances.

We also learn about how he expanded his work into sorting recycling, a very challenging problem. We also hear about the problems faced when using time of flight and sheet of light cameras. He then shares some good results using stereo vision, especially combined with blue light random dot projectors.

[ Robots in Depth ] Continue reading →

Posted in Human Robots

#434637 AI Is Rapidly Augmenting Healthcare and ...

Posted on February 15, 2019 by Android

When it comes to the future of healthcare, perhaps the only technology more powerful than CRISPR is artificial intelligence.

Over the past five years, healthcare AI startups around the globe raised over $4.3 billion across 576 deals, topping all other industries in AI deal activity.

During this same period, the FDA has given 70 AI healthcare tools and devices ‘fast-tracked approval’ because of their ability to save both lives and money.

The pace of AI-augmented healthcare innovation is only accelerating.

In Part 3 of this blog series on longevity and vitality, I cover the different ways in which AI is augmenting our healthcare system, enabling us to live longer and healthier lives.

In this blog, I’ll expand on:

Machine learning and drug design
Artificial intelligence and big data in medicine
Healthcare, AI & China

Let’s dive in.

Machine Learning in Drug Design
What if AI systems, specifically neural networks, could predict the design of novel molecules (i.e. medicines) capable of targeting and curing any disease?

Imagine leveraging cutting-edge artificial intelligence to accomplish with 50 people what the pharmaceutical industry can barely do with an army of 5,000.

And what if these molecules, accurately engineered by AIs, always worked? Such a feat would revolutionize our $1.3 trillion global pharmaceutical industry, which currently holds a dismal record of 1 in 10 target drugs ever reaching human trials.

It’s no wonder that drug development is massively expensive and slow. It takes over 10 years to bring a new drug to market, with costs ranging from $2.5 billion to $12 billion.

This inefficient, slow-to-innovate, and risk-averse industry is a sitting duck for disruption in the years ahead.

One of the hottest startups in digital drug discovery today is Insilico Medicine. Leveraging AI in its end-to-end drug discovery pipeline, Insilico Medicine aims to extend healthy longevity through drug discovery and aging research.

Their comprehensive drug discovery engine uses millions of samples and multiple data types to discover signatures of disease, identify the most promising protein targets, and generate perfect molecules for these targets. These molecules either already exist or can be generated de novo with the desired set of parameters.

In late 2018, Insilico’s CEO Dr. Alex Zhavoronkov announced the groundbreaking result of generating novel molecules for a challenging protein target with an unprecedented hit rate in under 46 days. This included both synthesis of the molecules and experimental validation in a biological test system—an impressive feat made possible by converging exponential technologies.

Underpinning Insilico’s drug discovery pipeline is a novel machine learning technique called Generative Adversarial Networks (GANs), used in combination with deep reinforcement learning.

Generating novel molecular structures for diseases both with and without known targets, Insilico is now pursuing drug discovery in aging, cancer, fibrosis, Parkinson’s disease, Alzheimer’s disease, ALS, diabetes, and many others. Once rolled out, the implications will be profound.

Dr. Zhavoronkov’s ultimate goal is to develop a fully-automated Health-as-a-Service (HaaS) and Longevity-as-a-Service (LaaS) engine.

Once plugged into the services of companies from Alibaba to Alphabet, such an engine would enable personalized solutions for online users, helping them prevent diseases and maintain optimal health.

Insilico, alongside other companies tackling AI-powered drug discovery, truly represents the application of the 6 D’s. What was once a prohibitively expensive and human-intensive process is now rapidly becoming digitized, dematerialized, demonetized and, perhaps most importantly, democratized.

Companies like Insilico can now do with a fraction of the cost and personnel what the pharmaceutical industry can barely accomplish with thousands of employees and a hefty bill to foot.

As I discussed in my blog on ‘The Next Hundred-Billion-Dollar Opportunity,’ Google’s DeepMind has now turned its neural networks to healthcare, entering the digitized drug discovery arena.

In 2017, DeepMind achieved a phenomenal feat by matching the fidelity of medical experts in correctly diagnosing over 50 eye disorders.

And just a year later, DeepMind announced a new deep learning tool called AlphaFold. By predicting the elusive ways in which various proteins fold on the basis of their amino acid sequences, AlphaFold may soon have a tremendous impact in aiding drug discovery and fighting some of today’s most intractable diseases.

Artificial Intelligence and Data Crunching
AI is especially powerful in analyzing massive quantities of data to uncover patterns and insights that can save lives. Take WAVE, for instance. Every year, over 400,000 patients die prematurely in US hospitals as a result of heart attack or respiratory failure.

Yet these patients don’t die without leaving plenty of clues. Given information overload, however, human physicians and nurses alone have no way of processing and analyzing all necessary data in time to save these patients’ lives.

Enter WAVE, an algorithm that can process enough data to offer a six-hour early warning of patient deterioration.

Just last year, the FDA approved WAVE as an AI-based predictive patient surveillance system to predict and thereby prevent sudden death.

Another highly valuable yet difficult-to-parse mountain of medical data comprises the 2.5 million medical papers published each year.

For some time, it has become physically impossible for a human physician to read—let alone remember—all of the relevant published data.

To counter this compounding conundrum, Johnson & Johnson is teaching IBM Watson to read and understand scientific papers that detail clinical trial outcomes.

Enriching Watson’s data sources, Apple is also partnering with IBM to provide access to health data from mobile apps.

One such Watson system contains 40 million documents, ingesting an average of 27,000 new documents per day, and providing insights for thousands of users.

After only one year, Watson’s successful diagnosis rate of lung cancer has reached 90 percent, compared to the 50 percent success rate of human doctors.

But what about the vast amount of unstructured medical patient data that populates today’s ancient medical system? This includes medical notes, prescriptions, audio interview transcripts, and pathology and radiology reports.

In late 2018, Amazon announced a new HIPAA-eligible machine learning service that digests and parses unstructured data into categories, such as patient diagnoses, treatments, dosages, symptoms and signs.

Taha Kass-Hout, Amazon’s senior leader in health care and artificial intelligence, told the Wall Street Journal that internal tests demonstrated that the software even performs as well as or better than other published efforts.

On the heels of this announcement, Amazon confirmed it was teaming up with the Fred Hutchinson Cancer Research Center to evaluate “millions of clinical notes to extract and index medical conditions.”

Having already driven extraordinary algorithmic success rates in other fields, data is the healthcare industry’s goldmine for future innovation.

Healthcare, AI & China
In 2017, the Chinese government published its ambitious national plan to become a global leader in AI research by 2030, with healthcare listed as one of four core research areas during the first wave of the plan.

Just a year earlier, China began centralizing healthcare data, tackling a major roadblock to developing longevity and healthcare technologies (particularly AI systems): scattered, dispersed, and unlabeled patient data.

Backed by the Chinese government, China’s largest tech companies—particularly Tencent—have now made strong entrances into healthcare.

Just recently, Tencent participated in a $154 million megaround for China-based healthcare AI unicorn iCarbonX.

Hoping to develop a complete digital representation of your biological self, iCarbonX has acquired numerous US personalized medicine startups.

Considering Tencent’s own Miying healthcare AI platform—aimed at assisting healthcare institutions in AI-driven cancer diagnostics—Tencent is quickly expanding into the drug discovery space, participating in two multimillion-dollar, US-based AI drug discovery deals just this year.

China’s biggest, second-order move into the healthtech space comes through Tencent’s WeChat. In the course of a mere few years, already 60 percent of the 38,000 medical institutions registered on WeChat allow patients to digitally book appointments through Tencent’s mobile platform. At the same time, 2,000 Chinese hospitals accept WeChat payments.

Tencent has additionally partnered with the U.K.’s Babylon Health, a virtual healthcare assistant startup whose app now allows Chinese WeChat users to message their symptoms and receive immediate medical feedback.

Similarly, Alibaba’s healthtech focus started in 2016 when it released its cloud-based AI medical platform, ET Medical Brain, to augment healthcare processes through everything from diagnostics to intelligent scheduling.

Conclusion
As Nvidia CEO Jensen Huang has stated, “Software ate the world, but AI is going to eat software.” Extrapolating this statement to a more immediate implication, AI will first eat healthcare, resulting in dramatic acceleration of longevity research and an amplification of the human healthspan.

Next week, I’ll continue to explore this concept of AI systems in healthcare.

Particularly, I’ll expand on how we’re acquiring and using the data for these doctor-augmenting AI systems: from ubiquitous biosensors, to the mobile healthcare revolution, and finally, to the transformative power of the health nucleus.

As AI and other exponential technologies increase our healthspan by 30 to 40 years, how will you leverage these same exponential technologies to take on your moonshots and live out your massively transformative purpose?

Join Me
Abundance-Digital Online Community: I’ve created a Digital/Online community of bold, abundance-minded entrepreneurs called Abundance-Digital. Abundance-Digital is my ‘onramp’ for exponential entrepreneurs – those who want to get involved and play at a higher level. Click here to learn more.

Image Credit: Zapp2Photo / Shutterstock.com Continue reading →

Posted in Human Robots